$1.04 Billion is the total value of Hudson Executive Capital LP's 11 reported holdings in Q2 2019. The portfolio turnover from Q1 2019 to Q2 2019 was 22.2% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| DB | Sell | DEUTSCHE BANK AGnamen akt | $1,000,148,000 | -36.9% | 129,722,952 | -33.3% | 48.17% | -2.1% |
| CATM | Sell | CARDTRONICS PLC | $444,056,000 | -48.8% | 16,253,866 | -33.3% | 21.39% | -20.6% |
| SPY | Sell | SPDR S&P 500 ETF TRput | $116,614,000 | -60.1% | 398,000 | -61.5% | 5.62% | -38.0% |
| USAT | Buy | USA TECHNOLOGIES INC | $106,928,000 | +336.9% | 14,391,440 | +144.0% | 5.15% | +577.6% |
| EGRX | Sell | EAGLE PHARMACEUTICALS INC | $90,400,000 | -38.5% | 1,623,554 | -44.3% | 4.35% | -4.7% |
| CVRS | Sell | CORINDUS VASCULAR ROBOTICS I | $84,844,000 | +14.2% | 28,471,090 | -33.3% | 4.09% | +77.1% |
| IWM | Sell | ISHARES TRput | $71,220,000 | -32.3% | 458,000 | -33.3% | 3.43% | +5.0% |
| SMG | New | SCOTTS MIRACLE GRO COcl a | $70,974,000 | – | 720,550 | +100.0% | 3.42% | – |
| STOR | Sell | STORE CAP CORP | $59,132,000 | -33.9% | 1,781,600 | -33.3% | 2.85% | +2.4% |
| NTRA | New | NATERA INC | $20,882,000 | – | 757,178 | +100.0% | 1.01% | – |
| ATRC | Sell | ATRICURE INC | $11,200,000 | -68.9% | 375,356 | -72.1% | 0.54% | -51.8% |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2019-08-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| DEUTSCHE BANK AG | 21 | Q3 2023 | 88.0% |
| EAGLE PHARMACEUTICALS INC | 16 | Q4 2019 | 34.5% |
| NATERA INC | 15 | Q4 2022 | 4.6% |
| CARDTRONICS PLC | 14 | Q1 2021 | 43.3% |
| VIEWRAY INC | 14 | Q2 2023 | 8.2% |
| ATRICURE INC | 13 | Q3 2019 | 20.9% |
| CIT GROUP INC | 11 | Q2 2018 | 26.4% |
| TIVITY HEALTH INC | 11 | Q1 2022 | 12.3% |
| CORINDUS VASCULAR ROBOTICS I | 11 | Q3 2019 | 9.7% |
| CANTALOUPE INC | 10 | Q3 2023 | 11.8% |
View Hudson Executive Capital LP's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| ViewRay, Inc. | July 21, 2023 | 6,752,093 | 3.7% |
| Akoya Biosciences, Inc. | February 07, 2023 | 1,892,204 | 5.0% |
| Liberated Syndication Inc. | March 23, 2022 | 2,400,000 | 8.6% |
| eHealth, Inc. | March 11, 2022 | 750,501 | 2.8% |
| Talkspace, Inc. | November 17, 2021 | 17,980,600 | 11.2% |
| USA TECHNOLOGIES INC | February 26, 2021 | 11,995,765 | 16.9% |
| Cardtronics plc | December 15, 2020 | 8,644,880 | 19.4% |
| TIVITY HEALTH, INC. | May 11, 2020 | 4,795,310 | 9.9% |
| EAGLE PHARMACEUTICALS, INC. | January 16, 2020 | 361,897 | 2.6% |
| Corindus Vascular Robotics, Inc.Sold out | October 31, 2019 | 0 | 0.0% |
View Hudson Executive Capital LP's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 144 | 2024-02-21 |
| 4 | 2024-02-21 |
| SC 13D/A | 2024-02-21 |
| 13F-HR | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-14 |
| SC 13D/A | 2023-07-21 |
| 13F-HR | 2023-05-15 |
| 13F-HR | 2023-02-14 |
| SC 13D/A | 2023-02-07 |
View Hudson Executive Capital LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.